Evidence map›Paper›PMID 28740898›Full record

ArticleAdvances in radiation oncology

Priority-driven plan optimization in locally advanced lung patients based on perfusion SPECT imaging.

Martha M Matuszak, Charles Matrosic, David Jarema, Daniel L McShan, Matthew H Stenmark, Dawn Owen, Shruti Jolly, Feng-Ming Spring Kong, Randall K Ten Haken

Abstract read
In one paragraph

Article in Advances in radiation oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Combining Serial and Parallel Functionality in Functional Lung Avoidance Radiation Therapy.International journal of radiation oncology, biology, physics · 2022
    Article
  7. Article
  8. Article
  9. Image-based lung functional radiotherapy planning for non-small cell lung cancer.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2020
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Martha M MatuszakDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Charles MatrosicDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
David JaremaDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Daniel L McShanDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Matthew H StenmarkDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Dawn OwenDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Shruti JollyDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Feng-Ming Spring KongDepartment of Radiation Oncology, Indiana University, Indianapolis, Indiana.
Randall K Ten HakenDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.

Funding

TREATMENT VERIFICATION AND TREATMENT PLAN REFINEMENTP01CA059827 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KESSLER, MARC LEWIS, LAWRENCE, THEODORE S · 1993 to 2018
$37.9M
FUNCTIONAL IMAGE AND MOLECULAR MARKER TO INDIVIDUALIZE ADAPTIVE RADIATION DOSE ESR01CA142840 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KONG, FENG-MING P. · 2010 to 2015
$2.0M
NCI NIH HHS P01 CA059827NCI NIH HHS R01 CA142840
6 · The paper itself

Abstract

purposeLimits on mean lung dose (MLD) allow for individualization of radiation doses at safe levels for patients with lung tumors. However, MLD does not account for individual differences in the extent or spatial distribution of pulmonary dysfunction among patients, which leads to toxicity variability at the same MLD. We investigated dose rearrangement to minimize the radiation dose to the functional lung as assessed by perfusion single photon emission computed tomography (SPECT) and maximize the target coverage to maintain conventional normal tissue limits. METHODS AND MATERIALS: Retrospective plans were optimized for 15 patients with locally advanced non-small cell lung cancer who were enrolled in a prospective imaging trial. A staged, priority-based optimization system was used. The baseline priorities were to meet physical MLD and other dose constraints for organs at risk, and to maximize the target generalized equivalent uniform dose (gEUD). To determine the benefit of dose rearrangement with perfusion SPECT, plans were reoptimized to minimize the generalized equivalent uniform functional dose (gEUfD) to the lung as the subsequent priority.

resultsWhen only physical MLD is minimized, lung gEUfD was 12.6 ± 4.9 Gy (6.3-21.7 Gy). When the dose is rearranged to minimize gEUfD directly in the optimization objective function, 10 of 15 cases showed a decrease in lung gEUfD of >20% (lung gEUfD mean 9.9 ± 4.3 Gy, range 2.1-16.2 Gy) while maintaining equivalent planning target volume coverage. Although all dose-limiting constraints remained unviolated, the dose rearrangement resulted in slight gEUD increases to the cord (5.4 ± 3.9 Gy), esophagus (3.0 ± 3.7 Gy), and heart (2.3 ± 2.6 Gy).

conclusionsPriority-driven optimization in conjunction with perfusion SPECT permits image guided spatial dose redistribution within the lung and allows for a reduced dose to the functional lung without compromising target coverage or exceeding conventional limits for organs at risk.

Identifiers

PMID28740898
PMCPMC5514230

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.